Non-Hodgkins Lymphoma

Showing 26 - 48 of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkins Lymphoma Trial in Kansas City (Rituximab)

Completed
  • Non-Hodgkins Lymphoma
  • Kansas City, Kansas
  • +1 more
Apr 19, 2017

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma Trial in United States (Food Safety Guidelines,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Food Safety Guidelines
  • Neutropenic Diet
  • San Diego, California
  • +5 more
Feb 7, 2017

Non-Hodgkins Lymphoma Trial in United States (Lenalidomide)

Completed
  • Non-Hodgkins Lymphoma
  • Scottsdale, Arizona
  • +7 more
Dec 17, 2015

Tumors, Hodgkins Disease, Non-Hodgkins Lymphoma Trial in San Antonio, Montreal (VLI)

Completed
  • Tumors
  • +2 more
  • San Antonio, Texas
  • +2 more
Sep 18, 2015

Non-Hodgkins Lymphoma Trial in United States (alemtuzumab)

Terminated
  • Non-Hodgkins Lymphoma
  • Aurora, Colorado
  • +16 more
Mar 4, 2015

Multiple Myeloma, Non-Hodgkins Lymphoma, Hodgkins Disease Trial in Durham (G-CSF plus Plerixafor)

Completed
  • Multiple Myeloma
  • +2 more
  • G-CSF plus Plerixafor
  • Durham, North Carolina
    Duke University Medical Center
Apr 8, 2014

Non-Hodgkins Lymphoma Trial in Canada, United States (Lenalidomide)

Completed
  • Non-Hodgkins Lymphoma
  • Scottsdale, Arizona
  • +14 more
Nov 6, 2013

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Amarillo (Busulfan, Clofarabine,

Terminated
  • Acute Myelogenous Leukemia
  • +8 more
  • Amarillo, Texas
    Texas Oncology
Nov 21, 2013

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Ann Arbor (TAK-901)

Completed
  • Acute Myeloid Leukemia
  • +11 more
  • Ann Arbor, Michigan
    University of Michigan
Jul 1, 2013

Hodgkin Disease, Non-Hodgkins Lymphoma Trial in Houston (Infusion of EBV Specific Cytotoxic T-Lymphocytes)

Terminated
  • Hodgkin Disease
  • Non-Hodgkins Lymphoma
  • Infusion of EBV Specific Cytotoxic T-Lymphocytes
  • Houston, Texas
  • +1 more
Nov 5, 2012

Breast Cancer, NSCLC, Non-Hodgkins Lymphoma Trial in Argentina (Vinorelbine Tartrate)

Completed
  • Breast Cancer
  • +2 more
  • Vinorelbine Tartrate
  • Buenos Aires, Argentina
  • +4 more
Jan 19, 2012

Blood Samples to Evaluate Biomarkers of Donor Chimerism

Completed
  • Leukemia
  • +3 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center
    Feb 13, 2012

    Non-Hodgkins Lymphoma Trial (FNHLId1, KLH + GM-CSF)

    Unknown status
    • Non-Hodgkins Lymphoma
    • FNHLId1
    • KLH + GM-CSF
    • (no location specified)
    Feb 1, 2012

    Brown Fat Activity and White Fat Accumulation

    Completed
    • Hodgkins Lymphoma
    • Non-hodgkins Lymphoma
      • Los Angeles, California
        Children's Hospital Los Angeles
      Jan 24, 2012

      Multiple Myeloma, Non-Hodgkins Lymphoma Trial in New York (Plerixafor)

      Unknown status
      • Multiple Myeloma
      • Non-Hodgkins Lymphoma
      • New York, New York
        Mount Sinai School of Medicine
      Sep 26, 2011

      Non-Hodgkins Lymphoma Trial in Nashville (Ifosfamide, Carboplatin, Etoposide)

      Completed
      • Non-Hodgkins Lymphoma
      • Nashville, Tennessee
        Tennessee Oncology, PLLC
      May 2, 2011

      Non-Hodgkins Lymphoma Trial (Rituximab, CHOP, CVP)

      Completed
      • Non-Hodgkins Lymphoma
      • (no location specified)
      Dec 29, 2010

      Non-Hodgkins Lymphoma Trial (Rituximab, Fludarabine, CAMPTH-1H)

      Completed
      • Non-Hodgkins Lymphoma
      • (no location specified)
      Dec 29, 2010

      High Dose Chemotherapy With Autologous Stem Cell Transplant in

      Completed
      • Non-Hodgkins Lymphoma
      • Autologous stem cell transplant
      • Sutton, Surrey, United Kingdom
        Royal Marsden NHS trust
      Jan 11, 2010

      Gemcitabine, Methylprednisolone Cisplatin With or Without

      Completed
      • Non-Hodgkins Lymphoma
      • Sutton, Surrey, United Kingdom
        Royal Marsden NHS trust
      Jan 11, 2010

      Non-Hodgkins Lymphoma Trial in Montreal (Rituximab, 90Y ibritumomab tiuxetan (Zevalin), Cyclophosphamide)

      Unknown status
      • Non-Hodgkins Lymphoma
      • Montreal, Quebec, Canada
        Hopital Maisonneuve-Rosemont
      Dec 10, 2008